Singapore Exchange Ltd (SGX) said on Tuesday the National Stock Exchange of India had applied for an interim injunction in an Indian court on SGX‘s new derivatives products, but SGX plans to go ahead and list them next month. “We have full confidence in our legal position and will vigorously defend this action. Our clients can continue to trade per normal.” SGX said in a statement.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
